Founder and CEO Christian Espinosa Will Join Panel on Data Governance and Patient Safety for Scalable HealthTech in the ...

Among large-cap U.S. MedTech companies, Boston Scientific BSX and Abbott ABT continue to attract significant investor focus.

A fault in J&J MedTech’s CEREPAK detachable coils, used in intracranial aneurysm embolisation procedures, has been associated with one death and four serious injuries.

Victoria-based company now has offices in Irvine, CA and Toronto, ON Many integrations fail, and I'm proud to say that ...

In combining the precision of the twiist insulin delivery system with the unmatched longevity of Eversense 365, Sequel and Senseonics are enhancing diabetes management by offering more tools to manage ...

This stock has climbed in the triple digits in recent years.

Medtech startups struggle with funding as strategic buyers consolidate, preferring fully developed products over early investments. What can innovators do?

Bloomberg reports that Johnson & Johnson (NYSE: JNJ) aims to sell its DePuy Synthes Orthopaedics business for more than $20 billion.

Medtronic achieved 8.7% revenue growth in its fiscal third quarter, reaching $9 billion for its highest growth in 10 quarters. Among other factors, the growth was driven by the company’s cardiac ...

Many healthcare medtech companies see ASCs as a top opportunity, and in recent years they’ve been looking for direct ways to get into the facilities. One are where this is clearest is orthopedics. For ...

The FDA has flagged J&J Medtech’s recall of its Cerepak detachable coils as Class I in the wake of one death and four serious ...

Coherent Sine-Burst Electroporation™ Platform demonstrates 100% procedural success and high freedom from AF in paroxysmal and persistent ...